Thromboembolism in inflammatory bowel disease: Results from a prospective, population-based European inception cohort

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 7, 2014, Pages 820-825

  Isene, Rune ^a,b   Bernklev, Tomm ^b,c   Hoie, Ole ^d   Langholz, Ebbe ^e   Tsianos, Epameonondas ^f   Stockbrügger, Reinhold ^g   Odes, Selwyn ^h   Småstuen, Milada ^a,b   Moum, Bjorn ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c TELEMARK HOSPITAL   (Norway)

^d Sorlandet Hospital   (Norway)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF IOANNINA   (Greece)

^g UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^h BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Crohn's disease; Thromboembolism; Ulcerative colitis

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; EUROPE; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; VERY ELDERLY; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PULMONARY EMBOLISM; VENOUS THROMBOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84903609073     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.910545     Document Type: Article

References (14)

1. Bargan JA, Barker NW. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936;58:17-31
2. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1964;5:1-22
3. Ricketts WE, Palmer WL. Complications of chronic non-specific ulcerative colitis. Gastroenterology 1946;7:55
4. Warren S, Sommer SC. Pathogenesis of ulcerative colitis. Am J Pathol 1949;25:657-79
5. Graef V, Baggenst AH, Sauer WG, Spittell JA. Venous thrombosis occurring in nonspecific ulcerative colitis - A necropsy study. Arch Intern Med 1966;117:377-82
6. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-5
7. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patientswith inflammatory bowel disease: A populationbased cohort study. Thromb Haemost 2001;85:430-4
8. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study. Lancet 2010;375:657-63
9. Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: A population-based nationwide study. Gut 2011;60: 937
10. Grip O, Svensson PJ, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000;35:619-23
11. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south?. Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-7
12. Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, et al. Cost-Analysis and cost-determinants in a European inflammatory bowel disease inception cohort with 10 years follow-up evaluation. Gastroenterology 2006; 131:719-28
13. Wolters FL, van Zeijl G, Sijbrandij J, Wessels F, O'Morain C, Limonard C, et al. Internet-based data inclusion in a European epidemiological follow-up study of IBD patients: A description of methods used. World J Gastroenterol 2005;11:7152-8
14. Pleet JL, Vaughn BP, Morris JA, Moss AC, Cheifetz AS. The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis. Aliment Pharmacol Ther 2014;doi: 10.1111/ apt.12691.